1.98
-0.12(-5.71%)
Currency In USD
Previous Close | 2.1 |
Open | 2.08 |
Day High | 2.15 |
Day Low | 1.98 |
52-Week High | 5.24 |
52-Week Low | 1.61 |
Volume | 12,943 |
Average Volume | 34,240 |
Market Cap | 81.41M |
PE | -1.5 |
EPS | -1.32 |
Moving Average 50 Days | 1.93 |
Moving Average 200 Days | 3.06 |
Change | -0.12 |
If you invested $1000 in Elutia Inc. (ELUT) since IPO date, it would be worth $136.55 as of July 01, 2025 at a share price of $1.98. Whereas If you bought $1000 worth of Elutia Inc. (ELUT) shares 3 years ago, it would be worth $292.47 as of July 01, 2025 at a share price of $1.98.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method
GlobeNewswire Inc.
May 28, 2025 12:00 PM GMT
— Innovative approach accelerates new product development and testing —SILVER SPRING, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced th
Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio
GlobeNewswire Inc.
May 01, 2025 8:05 PM GMT
Move expected to drive both top-line growth and gross margin improvement SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced it
Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
GlobeNewswire Inc.
May 01, 2025 12:00 PM GMT
SILVER SPRING, Md., May 01, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its first quarter 2025 financial results after marke